Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase
Open Access
- 1 January 2016
- journal article
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 26 (1) , 114-120
Abstract
Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin . fecal M2-type pyruvate kinaseKeywords
This publication has 19 references indexed in Scilit:
- The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase TestGut and Liver, 2015
- Aberrant methylation patterns in cancer: a clinical viewBiochemia Medica, 2015
- Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohortEuropean Journal of Gastroenterology & Hepatology, 2014
- Population-based colorectal cancer screening: comparison of two fecal occult blood testFrontiers in Pharmacology, 2014
- The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening.2012
- Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysisWorld Journal of Gastroenterology, 2012
- Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cellsThe International Journal of Biochemistry & Cell Biology, 2011
- [Ouality indicators for the evaluation of colorectal cancer screening programmes].2008
- Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical interventionColorectal Disease, 2007
- Comparing Attendance and Detection Rate of Colonoscopy With Sigmoidoscopy and FIT for Colorectal Cancer ScreeningGastroenterology, 2007